Transcriptomics

Dataset Information

0

Discovery of pan-Histone Acetyltransferase Inhibitors with Potent Antitumor Activity in vivo

ABSTRACT: we use MV4-11 as cellular models to analyze differential gene expression.

ORGANISM(S): Homo sapiens

PROVIDER: GSE104522 | GEO | 2017/10/03

SECONDARY ACCESSION(S): PRJNA412905

REPOSITORIES: GEO

Json Xml

Similar Datasets

Genomics Discovery of pan-Histone Acetyltransferase Inhibitors with Potent Antitumor Activity in vivo
| PRJNA412905 | ENA
Unknown Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo Activity.
| S-EPMC7073891 | biostudies-literature
Unknown Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity.
| S-EPMC4007912 | biostudies-literature
Transcriptomics Expression Profiling of Mixed Lineage Leukemia Cells Treated with a Potent Small-Molecule DOT1L Inhibitor
2011-07-11 | E-GEOD-29828 | biostudies-arrayexpress
Unknown Structure-based design of potent Bcl-2/Bcl-xL inhibitors with strong in vivo antitumor activity.
| S-EPMC3417242 | biostudies-literature
Unknown Novel Pan-Pim Kinase Inhibitors With Imidazopyridazine and Thiazolidinedione Structure Exert Potent Antitumor Activities.
| S-EPMC8126654 | biostudies-literature
Unknown Antitumor activity of pan-HER inhibitors in HER2-positive gastric cancer.
| S-EPMC5891184 | biostudies-literature
Unknown Discovery of the first N-hydroxycinnamamide-based histone deacetylase 1/3 dual inhibitors with potent oral antitumor activity.
| S-EPMC4030833 | biostudies-literature
Transcriptomics Structure-Based Discovery of Potent WD Repeat Domain 5 Inhibitors that Demonstrate Efficacy and Safety in Preclinical Animal Models
2022-10-01 | GSE203101 | GEO
Transcriptomics Antiproliferative and Apoptotic Activities of Sequence-Specific Histone Acetyltransferase Inhibitors
2017-06-28 | GSE100466 | GEO